Rasagiline
- Product NDC
- 47781-683
- 11-digit product format
- 477810683
- Labeler code
- 47781
- Product ID
- 47781-683_9726c72c-4d6a-6707-a9bf-e3716476f816
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Rasagiline
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Alvogen, Inc.
- Application
- ANDA201970
- Marketing category
- ANDA
- Marketing start
- 2019-03-01
- Substance
- RASAGILINE MESYLATE
- Active strength
- .5 mg/1
- Pharmacologic classes
- Monoamine Oxidase Inhibitor [EPC], Monoamine Oxidase Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Rasagiline
- Listing expiration
- 2026-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| RASAGILINE MESYLATE | .5 mg/1 |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | LH8C2JI290 |
| Rxcui | 608328, 636664 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 47781-683-30 | Rasagiline | 30 in 1 BOTTLE, PLASTIC | TABLET | 30 | | 7 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 47781-683 | RASAGILINE TABLET [ALVOGEN, INC.] | 6 | Current NDC, Legacy NDC, 1 package rows | 20241012_a62a9946-755f-47d0-afe6-edc8f7d641fe.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 47781-683-30 | 47781068330 | 30 TABLET in 1 BOTTLE, PLASTIC (47781-683-30) | 30 tablet | 2019-03-01 | 0000-00-00 | No | No | Current |